On the second day of the Medlab Middle East 2024 exhibition, Norman continued to demonstrate its leadership and innovation in the medical industry, attracting considerable attention from attendees. In addition to the NORMAN-CL211 fully automated chemiluminescence analyzer, Norman also showcased a range of immunofluorescence analyzers, including the FI-1000, FI-1000B, and FI-1200. Serving as point-of-care testing (POCT) devices, these analyzers are capable of meeting the diverse testing needs across various settings, garnering significant interest from healthcare professionals and industry representatives. The immunofluorescence analyzers offer rapid and accurate testing capabilities for diagnosing and monitoring various diseases. Representatives from Norman provided live demonstrations of the operation and performance of these analyzers, attracting a crowd of interested viewers and inquiries. Attendees showed keen interest in the potential applications of these POCT devices in medical practice and engaged in active discussions and interactions with Norman representatives. Norman's presence at the exhibition further underscores the company's leadership and innovation in the field of medical technology. By showcasing a diverse range of medical solutions, Norman provides healthcare professionals with more options and possibilities for medical diagnosis and treatment.

At the Medlab Middle East exhibition held in Dubai on February 5, 2024, Norman, a leading global manufacturer of medical equipment, showcased their latest fully automated chemiluminescence analyzer, the NORMAN-CL211. This highlight product attracted a large number of attendees and generated enthusiastic interest. The distinctive feature of the NORMAN-CL211 lies in its rapid, automated whole blood testing capabilities. Compared to traditional testing methods, this instrument can complete whole blood testing and generate detailed reports in just 7 minutes. This technological innovation brings tremendous convenience to medical diagnosis and treatment, garnering widespread attention from healthcare professionals and relevant industries. Norman's booth became a major highlight of the exhibition, drawing in numerous visitors eager to learn about their latest products. Attendees showed strong interest in the performance and capabilities of the NORMAN-CL211, expressing appreciation for its rapid and accurate testing abilities.

On the auspicious day of January 14th, the grand stage of Nanjing Norman Biological Technology illuminated with the success of our annual meeting! Chairman Mr. He Shizhao graced the occasion with an electrifying speech that echoed through the halls, resonating with the triumph of achieving our sales target. As he stood before the assembled team, Mr. He Shizhao's words painted a vivid picture of accomplishment, a canvas brushed with the dedication and hard work of each member. The annual speech became a symphony of praise, acknowledging the collective efforts that propelled us to surpass expectations and reach new heights. With the dawn of the new year, the spirit of Norman blazes anew! A rallying call echoes through the corridors, urging us to unite once more in our pursuit of excellence throughout 2024. The gratitude felt for the unwavering commitment of every team member is profound, setting the stage for a future where we continue our journey of remarkable achievements. Together, as a cohesive force, we eagerly anticipate the unfolding chapters of success that await us in the coming year. Let our collective efforts be the guiding light, illuminating the path toward a brilliantly bright future for Norman!

We here to announce our exhibition list of 2024. We warmly welcome your visit. Exhibiton Name Place Time Medlab Middle East 2024 Dubai, United Arab Emirates 02.05-02.08 Vietnam Medi-Pharm 2024 Hanoi, Vietnam 05.09-05.12 Asia Health & Medlab Asia 2024 Bangkok, Thailand 07.10-07.12 MEDITECH 2024 Bogota, Colombia 07.09-07.12 MEDICAL PHILIPPINES 2024 Manila, Philippines 8.14-8.16 Hospital Expo 2024 Jakarta, Indonesia 10.16-10.19 MEDICA 2024 Dusseldorf, Germany 11.11-11.14

Happy New Year! Thans for your companionship over the past year. In this moment of bidding farewell to the old and embracing the new, let's welcome the coming year full of hope and opportunities. Growing together with you. Norman is poised to embark on a journey of shared progress and achievements. The past year has seen us through challenges and successes alike. In the upcoming year, let's continue our journey hand in hand, putting in collective effort and determination. In an atmosphere of unity and collaboration, we are sure to achieve even greater milestones. May the new year bring fresh insights and innovations, allowing us to thrive through cooperation and continuous improvement. Wishing you and your loved ones health, happiness, and prosperity in the coming year. Let's strive together to make tomorrow even brighter. Happy New Year!

Norman Biotech to Unveil Revolutionary CLIA Analyzer at MEDLAB MIDDLE EAST 2024 Norman Biotech proudly announces its participation in the upcoming MEDLAB MIDDLE EAST exhibition from February 5th to 8th, 2024, in Dubai. Norman will be showcasing its latest innovation, the NORMAN-CL211 chemiluminescence analyzer, at Booth Z2.C19 during the event. The NORMAN-CL211, a flagship product of Norman, has garnered widespread attention for its outstanding performance and cutting-edge technology. Notably, this chemiluminescence analyzer stands out for its remarkable speed, delivering test reports within a unique 7-minute timeframe, making it one of the fastest CLIA analyzers currently available. Furthermore, the NORMAN-CL211 is capable of providing test reports using whole blood within seven minutes, catering to urgent scenarios such as emergencies. With applications extending to areas like cardiovascular diseases and inflammation, the NORMAN-CL211 has demonstrated significant success. Its high-speed and high-sensitivity detection capabilities make it an indispensable tool in medical laboratories, offering healthcare professionals quicker and more accurate diagnostic results. Norman will showcase the comprehensive capabilities of the NORMAN-CL211 at the exhibition, inviting attendees to experience this innovative technology firsthand. We look forward to welcoming visitors to Booth Z2.C19, where we can collectively explore the latest advancements in In-vitro Diagnostics and contribute to the future of healthcare technology.

Merry Christmas In this season of warmth and joy, Norman Medical Group extends our sincerest Christmas wishes to you and your loved ones! This year has brought many challenges, but it has also seen us overcome difficulties together. On this special occasion, let's celebrate our shared resilience, courage, and the appreciation for good health. Norman Medical has been committed to providing you with outstanding healthcare, be it in your treatment journeys or daily health needs. On this special day, we want to express our gratitude for your continued trust and support. May you feel the warmth of family gatherings, the joy of laughter, and the blessings of good health this Christmas. Norman Medical Group pledges to continue walking with you in the coming year, delivering high-quality, comprehensive medical care. Thank you for being a part of the Norman family. Wishing you and your family a Christmas filled with love and laughter, and a Happy New Year!

From December 7th to 9th, Norman participated in the 6th China Maternal and Child Clinical Diagnosis and Laboratory Medicine Conference. Norman has consistently prioritized the field of women's and children's health. In response to the challenge of difficult venous blood collection in children, Norman has developed a series of peripheral blood testing projects. Coupled with the seven-minute reporting time of Norman-CL211, these initiatives provide a rapid and convenient solution for pediatric outpatient and emergency testing.